Eesha Chakraborty

About

Eesha Chakraborty is a Postdoctoral Researcher at the Massey Comprehensive Cancer Center, Virginia Commonwealth University (VCU). She earned her B.Sc. in Biochemistry, Genetics, and Microbiology from Bangalore University, India, and an M.Sc. in Applied Microbiology from KIIT University, Orissa, India. She began her research career as a Junior Research Fellow at KIIT University, focusing on the characterization of a hypothetical protein from Salmonella enterica and the development of antibodies in rabbit models for molecular studies.

Eesha received a full scholarship for her Ph.D. at VCU in Clinical and Translational Sciences (2021) and is currently a postdoctoral research associate in the Department of Pharmacology and Toxicology, specializing in cancer biology and molecular medicine. Her expertise includes Microbiology, Genetics, Biochemistry, and Molecular Biology, with a focus on translational oncology, pharmacology, and toxicology

Employment

• Massey Comprehensive Cancer Center Post doctoral researcher
  2025 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Promotion of Tumor Cell Senescence by the Antibody–Drug Conjugate, Sacituzumab Govitecan
  Molecular Pharmacology 2026 DOI: 10.1016/j.molpha.2026.100142
  +Save
• Interrogating the Involvement of Autophagy, Senescence, and the Immune System in the Actions of Sacituzumab Govitecan as an Anticancer Agent
  Frontiers in Bioscience-Landmark 2025 DOI: 10.31083/FBL39310
  +Save
• Androgen deprivation-induced senescence confers sensitivity to a senolytic strategy in prostate cancer
  Biochemical Pharmacology 2024 DOI: 10.1016/j.bcp.2024.116385
  +Save
• The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells
  Biomedicines 2023 DOI: 10.3390/biomedicines11113066
  +Save
• BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer
  Cancers 2023 DOI: 10.3390/cancers15164066
  +Save
• Emerging Therapies for Hepatocellular Carcinoma (HCC)
  Cancers 2022 DOI: 10.3390/cancers14112798
  +Save
• Altered virulence potential of Salmonella Enteritidis cultured in different foods: A cumulative effect of differential gene expression and immunomodulation
  International Journal of Food Microbiology 2016 DOI: 10.1016/j.ijfoodmicro.2016.04.012
  +Save